NCT04072029View on ClinicalTrials.gov

Risk Assessment for Progression to DMEK Following Cataract Surgery in Fuchs Endothelial Corneal Dystrophy

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Fuchs' Endothelial DystrophyCataract
Interventions
PROCEDURE

Phacoemulsification with intraocular lens implantation

Phacoemulsification (2.2mm coaxial, viscoelastic shield, experienced surgeon) with intraocular lens implantation (acrylic hidrophobic)

Trial Locations (1)

28034

Hospital Universitario Ramón y Cajal, Madrid

All Listed Sponsors
lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT04072029 - Risk Assessment for Progression to DMEK Following Cataract Surgery in Fuchs Endothelial Corneal Dystrophy | Biotech Hunter | Biotech Hunter